Cost-Effectiveness of Teriparatide Compared With Alendronate and Risedronate for the Treatment of Postmenopausal Osteoporosis Patients in Iran

Medical Journal of the Islamic Republic of Iran - Iran
doi 10.14196/mjiri.31.39
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

IUMS Press

Related search

A Systematic Review and Economic Evaluation of Alendronate, Etidronate, Risedronate, Raloxifene and Teriparatide for the Prevention and Treatment of Postmenopausal Osteoporosis

Health Technology Assessment
MedicineHealth Policy
2005English

Monthly Risedronate for the Treatment of Postmenopausal Osteoporosis

Pharmaceutica Analytica Acta
2014English

Pms63 - Cost-Effectiveness of Actonel® 35 Mg (Risedronate) Gastro-Resistant Tablets for the Treatment of Postmenopausal Women With Osteoporosis in France

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Impact of Generic Alendronate Cost on the Cost-Effectiveness of Osteoporosis Screening and Treatment

PLoS ONE
Multidisciplinary
2012English

PMS71 Cost-Effectiveness of Alendronate Therapy for Osteopenic Postmenopausal Women in Japan

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Treatment Responses With Once-Weekly Teriparatide Therapy for Osteoporosis

Osteoporosis International
MedicineEndocrinologyMetabolismDiabetes
2016English

Pms47 - Cost-Effectiveness of Tofacitinib Compared With Adalimumab in the Treatment of Moderate to Severe Rheumatoid Arthritis in Iran

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

FRI0566 Teriparatide and Alendronate Improved Bone Loss and Hyperalgesia in a Mouse Model of Osteoporosis

2017English

Greater First Year Effectiveness Drives Favorable Cost-Effectiveness of Brand Risedronate Versus Generic or Brand Alendronate: Modeled Canadian Analysis

Osteoporosis International
MedicineEndocrinologyMetabolismDiabetes
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy